Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Clinical Applications of Epidermal Stem Cells

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Multi-level responses of Camellia reticulata to heat stress: insights from photosynthetic performance, antioxidant activity, lipidomics, and fatty acid profiling.

BMC plant biology·2026

Same author

Effectiveness of digital inhaled therapy management and respiratory muscle training in moderate to severe COPD patients: study protocol for a randomized controlled, assessor-blinded, multicenter trial.

Trials·2026

Same author

A damage constitutive model of carbonaceous shale containing a single crack under drying-weting cycles and triaxial compression.

Scientific reports·2026

Same author

Dual checkpoint blockade of PD-1 and Tim-3 by engineered hybrid nanovesicles for enhanced cancer immunotherapy.

Frontiers in immunology·2026

Same author

CUL4B promotes hepatocellular carcinoma progression and oxaliplatin resistance by facilitating FUS degradation.

Cell death & disease·2025

Same author

PD-L1 nanobody-engineered bacterial outer membrane vesicles delivering cuproptosis micelles for potentiated cancer immunotherapy.

Biomaterials advances·2025

Search research articles

Related Experiment Video

Updated: Aug 12, 2025

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles

Published on: January 4, 2012

Engineered elastin-like polypeptides: An efficient platform for enhanced cancer treatment.

Aiguo Jiang¹, Xinqiang Guan², Lianping He³

¹Department of Respiratory Medicine, Taizhou University Affiliated Wenling Hospital, Taizhou University, Taizhou, China.

Frontiers in Pharmacology

|January 26, 2023

Summary

Elastin-like polypeptides (ELPs) offer advanced drug delivery systems for cancer treatment. These synthetic peptides improve drug loading, efficiency, and antitumor efficacy by enhancing pharmacokinetics and biodistribution.

Keywords:

cancer therapy drug delivery elastin-like polypeptide inverse transition cycling nanoparticle

More Related Videos

Production of Elastin-like Protein Hydrogels for Encapsulation and Immunostaining of Cells in 3D

Production of Elastin-like Protein Hydrogels for Encapsulation and Immunostaining of Cells in 3D

Published on: May 19, 2018

Design and Construction of Artificial Extracellular Matrix aECM Proteins from Escherichia coli for Skin Tissue Engineering

Design and Construction of Artificial Extracellular Matrix aECM Proteins from Escherichia coli for Skin Tissue Engineering

Published on: June 11, 2015

Related Experiment Videos

Last Updated: Aug 12, 2025

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles

Published on: January 4, 2012

Production of Elastin-like Protein Hydrogels for Encapsulation and Immunostaining of Cells in 3D

Production of Elastin-like Protein Hydrogels for Encapsulation and Immunostaining of Cells in 3D

Published on: May 19, 2018

Design and Construction of Artificial Extracellular Matrix aECM Proteins from Escherichia coli for Skin Tissue Engineering

Design and Construction of Artificial Extracellular Matrix aECM Proteins from Escherichia coli for Skin Tissue Engineering

Published on: June 11, 2015

Area of Science:

Biomaterials Science
Nanotechnology
Oncology

Background:

Drug delivery systems (DDSs) are crucial for enhancing therapeutic agent efficacy in cancer treatment.
Elastin-like polypeptides (ELPs), derived from tropoelastin, possess unique properties like biocompatibility, degradability, and temperature-responsiveness.
ELPs offer tunable structures and functions, making them promising for advanced biomedical applications.

Purpose of the Study:

To review the recent applications of ELP-based drug delivery systems in cancer therapy.
To highlight the advantages of ELPs in improving drug loading and delivery efficiency.
To summarize the use of ELPs for delivering various therapeutic agents against cancer.

Main Methods:

Literature review of recent studies on ELP applications in cancer treatment.
Analysis of ELP properties relevant to drug delivery, including biocompatibility, degradability, and responsiveness.
Categorization of ELP-based delivery for functional peptides, therapeutic proteins, small molecule drugs, and photosensitizers.

Main Results:

ELPs demonstrate significant potential in improving drug loading and delivery efficiency for cancer therapy.
ELP-based DDSs enhance the pharmacokinetics and biodistribution of therapeutic agents.
ELPs have shown promise in delivering diverse therapeutic payloads, leading to improved antitumor efficacy.

Conclusions:

ELP-based drug delivery systems represent a promising strategy for advancing cancer treatment.
The unique properties of ELPs facilitate the development of effective and targeted cancer therapies.
Further research into ELP applications can lead to novel therapeutic approaches for various cancers.